These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 34593460)

  • 1. Can D3 Lymph Node Dissection for Patients With Colon Cancer With a Poor C-Reactive Protein/Albumin Ratio Improve Survival Outcomes?
    Atsumi Y; Numata M; Kazama K; Kawahara S; Ju M; Iguchi K; Sawazaki S; Aoyama T; Tamagawa A; Sato S; Higuchi A; Sugano N; Godai T; Tamagawa H; Saeki H; Oshima T; Shiozawa M; Yukawa N; Rino Y
    Anticancer Res; 2021 Oct; 41(10):5097-5106. PubMed ID: 34593460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. D3 lymph node dissection reduces recurrence after primary resection for elderly patients with colon cancer.
    Numata M; Sawazaki S; Aoyama T; Tamagawa H; Sato T; Saeki H; Saigusa Y; Taguri M; Mushiake H; Oshima T; Yukawa N; Shiozawa M; Rino Y; Masuda M
    Int J Colorectal Dis; 2019 Apr; 34(4):621-628. PubMed ID: 30659360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic impact of lymph node dissection is different for male and female colon cancer patients: a propensity score analysis in a multicenter retrospective study.
    Ishihara S; Otani K; Yasuda K; Nishikawa T; Tanaka T; Tanaka J; Kiyomatsu T; Kawai K; Hata K; Nozawa H; Kazama S; Yamaguchi H; Sunami E; Kitayama J; Sugihara K; Watanabe T
    Int J Colorectal Dis; 2016 Jun; 31(6):1149-55. PubMed ID: 27023629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of D3 lymph node dissection on survival for patients with T3 and T4 colon cancer.
    Kotake K; Mizuguchi T; Moritani K; Wada O; Ozawa H; Oki I; Sugihara K
    Int J Colorectal Dis; 2014 Jul; 29(7):847-52. PubMed ID: 24798631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-term outcomes of complete mesocolic excision versus D2 dissection in patients undergoing laparoscopic colectomy for right colon cancer (RELARC): a randomised, controlled, phase 3, superiority trial.
    Xu L; Su X; He Z; Zhang C; Lu J; Zhang G; Sun Y; Du X; Chi P; Wang Z; Zhong M; Wu A; Zhu A; Li F; Xu J; Kang L; Suo J; Deng H; Ye Y; Ding K; Xu T; Zhang Z; Zheng M; Xiao Y;
    Lancet Oncol; 2021 Mar; 22(3):391-401. PubMed ID: 33587893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Lymph Node Dissection on Thymic Malignancies: Multi-Institutional Propensity Score Matched Analysis.
    Hwang Y; Kang CH; Park S; Lee HJ; Park IK; Kim YT; Lee GD; Kim HR; Choi SH; Kim YH; Kim DK; Park SI; Shin S; Cho JH; Kim HK; Choi YS; Kim J; Zo JI; Shim YM; Lee CY; Lee JG; Kim DJ; Paik HC; Chung KY
    J Thorac Oncol; 2018 Dec; 13(12):1949-1957. PubMed ID: 30217490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. D3 Lymph Node Dissection in Right Hemicolectomy with a No-touch Isolation Technique in Patients With Colon Cancer.
    Kanemitsu Y; Komori K; Kimura K; Kato T
    Dis Colon Rectum; 2013 Jul; 56(7):815-24. PubMed ID: 23739187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of D3 lymph node dissection on upstaging and short-term survival in clinical stage I right-sided colon cancer.
    Kim JS; Baek SJ; Kwak JM; Kim J; Kim SH; Ji WB; Kim JS; Hong KD; Um JW; Kang SH; Lee SI; Min BW
    Asian J Surg; 2021 Oct; 44(10):1278-1282. PubMed ID: 33752988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term outcomes of D2 vs. D3 lymph node dissection for cT2N0M0 colorectal cancer: a multi‑institutional retrospective analysis.
    Kojima T; Hino H; Shiomi A; Kagawa H; Yamaoka Y; Manabe S; Chen K; Nanishi K; Yamauchi S; Sugihara K
    Int J Clin Oncol; 2022 Nov; 27(11):1717-1724. PubMed ID: 36029376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of laparoscopic and open D3 lymphadenectomy for transverse colon cancer.
    Kwak HD; Ju JK; Lee SY; Kim CH; Kim YJ; Kim HR
    Int J Colorectal Dis; 2017 Dec; 32(12):1733-1739. PubMed ID: 28879395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of D2 vs D3 lymph node dissection for RIght COloN cancer (RICON): study protocol for an international multicenter open-label randomized controlled trial.
    Balaban V; Mutyk M; Bondarenko N; Zolotukhin S; Sovpel O; Sovpel I; Zykov D; Rublevskiy I; Klochkov M; Prado AP; He M; Tsarkov P
    Trials; 2024 Jul; 25(1):438. PubMed ID: 38956698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Long-term oncological outcomes after laparoscopic versus abdominal radical hysterectomy in stage I a2- II a2 cervical cancer: a matched cohort study].
    Wang W; Shang C; Huang J; Chen S; Shen H; Yao S
    Zhonghua Fu Chan Ke Za Zhi; 2015 Dec; 50(12):894-901. PubMed ID: 26887872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-term outcomes of a multicentre randomized clinical trial comparing D2 versus D3 lymph node dissection for colonic cancer (COLD trial).
    Karachun A; Panaiotti L; Chernikovskiy I; Achkasov S; Gevorkyan Y; Savanovich N; Sharygin G; Markushin L; Sushkov O; Aleshin D; Shakhmatov D; Nazarov I; Muratov I; Maynovskaya O; Olkina A; Lankov T; Ovchinnikova T; Kharagezov D; Kaymakchi D; Milakin A; Petrov A
    Br J Surg; 2020 Apr; 107(5):499-508. PubMed ID: 31872869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic impact of primary tumor resection and lymph node dissection in stage IV colorectal cancer with unresectable metastasis: a propensity score analysis in a multicenter retrospective study.
    Ishihara S; Hayama T; Yamada H; Nozawa K; Matsuda K; Miyata H; Yoneyama S; Tanaka T; Tanaka J; Kiyomatsu T; Kawai K; Nozawa H; Kanazawa T; Kazama S; Yamaguchi H; Sunami E; Kitayama J; Hashiguchi Y; Sugihara K; Watanabe T
    Ann Surg Oncol; 2014 Sep; 21(9):2949-55. PubMed ID: 24763981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing 5-Year Survival Rates Before and After Re-stratification of Stage I-III Right-Sided Colon Cancer Patients by Establishing the Presence/Absence of Occult Tumor Cells and Lymph Node Metastases in the Different Levels of Surgical Dissection.
    Banipal GS; Stimec BV; Andersen SN; Faerden AE; Edwin B; Baral J; Nesgaard JM; Benth JŠ; Ignjatovic D;
    J Gastrointest Surg; 2022 Oct; 26(10):2201-2211. PubMed ID: 36036877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of long term survival outcomes between D1+ and D2 lymph node dissection for ≥ pT2 or pN+ gastric carcinoma: A large scale case-control study using propensity score matching.
    Kang JH; Ryu SY; Jung MR; Jeong O
    Eur J Surg Oncol; 2020 Jul; 46(7):1239-1246. PubMed ID: 32331983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short- and long-term outcomes of preservation versus ligation of the inferior mesenteric artery in laparoscopic D3 lymph node dissection for descending colon cancer: a propensity score-matched analysis.
    Sato A; Imaizumi K; Kasajima H; Ichimura K; Sato K; Yamana D; Tsuruga Y; Umehara M; Kurushima M; Nakanishi K
    Langenbecks Arch Surg; 2023 Jan; 408(1):23. PubMed ID: 36637543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [D2 and D3 lymph node dissection for colon cancer].
    Kit OI; Gevorkyan YA; Karachun AM; Soldatkina NV; Bondarenko OK; Kolesnikov VE
    Khirurgiia (Mosk); 2024; (7):25-35. PubMed ID: 39008695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. D3 Lymph Node Dissection Improves Survival Outcomes in Patients With cT2 Colorectal Non-well-differentiated Adenocarcinoma.
    Wang L; Song B; Chen Y; Hirano Y
    In Vivo; 2024; 38(2):807-818. PubMed ID: 38418105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protocol for a multicentre randomized clinical trial comparing oncological outcomes of D2
    Karachun A; Petrov A; Panaiotti L; Voschinin Y; Ovchinnikova T
    BJS Open; 2019 Jun; 3(3):288-298. PubMed ID: 31183444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.